V. Craig Jordan
Academic
Who is V. Craig Jordan?
Virgil Craig Jordan, OBE, PhD, DSc, FMedSci is a scientist specializing in drugs for breast cancer treatment and prevention. Currently Scientific Director and Vice Chairman of Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University, Jordan was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones. More recently his work has branched out into the prevention of multiple diseases in women with the discovery of the drug group, selective estrogen receptor modulator.
A highly regarded researcher, his paper The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women - Results from the more Randomized Trial was one of the top 20 most cited papers in breast cancer research during 2003 and 2004.
We need you!
Help us build the largest biographies collection on the web!
- Spouses
- Nationality
- United States of America
- United Kingdom
- Education
- University of Leeds
- Employment
- Northwestern University
- University of Leeds
- Lived in
- United Kingdom
Submitted
on July 23, 2013
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"V. Craig Jordan." Biographies.net. STANDS4 LLC, 2024. Web. 28 Mar. 2024. <https://www.biographies.net/people/en/v_craig_jordan>.
Discuss this V. Craig Jordan biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In